BPI Labs
BPI Labs is a 503B outsourcing facility based in Largo, FL. A government record names tirzepatide and liraglutide at BPI Labs; the newest is an FDA inspection report (Form 483) dated April 17, 2026. It fills prescriptions; it doesn’t write them, so you can’t get a GLP-1 from BPI Labs without a prescription from a licensed clinician.1
How to get a GLP‑1 filled by BPI LabsChecked November 20, 2026 against FDA, CMS and state board records. Every fact links to its source.
BPI Labs at a glance
How to get a GLP‑1 filled by BPI Labs
To get a GLP‑1 from BPI Labs, you first need a prescription: it fills prescriptions; it doesn’t write them or sell without one. An online program takes you through the steps: you fill in a health questionnaire, a licensed clinician reviews it, and if they prescribe, the program’s pharmacy ships the medication to you.
1 program we review names BPI Labs among its pharmacies; they’re listed below. These are the three programs ranked highest on our score.
- 1Health questionnaire, online
- 2A licensed clinician decides
- 3The pharmacy ships to you
We may earn a commission when you sign up through some links. It never changes our order or scores. How we make money
Prefer your own clinician? You’re free to: ask them to send your prescription to BPI Labs or another licensed pharmacy.
See every program we rankWhat ties BPI Labs to GLP‑1s
- FDA inspection report (Form 483)April 17, 2026 · tirzepatide and liraglutideFDA Form 483 inspectional observations, BPI Labs, LLC, issued 2026-04-174
“Liraglutide Injection, 18 mg/3 mL (6 mg/mL)”
BPI Labs’s FDA record
| Date | What the FDA did |
|---|---|
| April 17, 2026 | 483 Issued 04/17/20264 |
| July 28, 2025 | FMD-145 Letter Issued 07/28/2025 |
| February 21, 2025 | 483 Issued 02/21/20255 |
| September 1, 2021 | FMD-145 Letter Issued 09/01/2021 |
| April 30, 2021 | 483 Issued 04/30/20216 |
Telehealth programs that use BPI Labs
What a compounded GLP‑1 is, and what it isn’t
The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn’t review their safety, effectiveness or quality before they’re sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12.910 Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility.87
BPI Labs: questions
- 1.BPI Labs: what it says it isbpi-labs.comretrieved 2026-11-20↩“BPI is an FDA registered drug manufacturer and 503B outsourcing facility.”
- 2.Registered Outsourcing FacilitiesU.S. Food and Drug Administrationretrieved 2026-11-20↩
- 3.Belle, a GLP-1 telehealth program, names it among its pharmaciesBelleretrieved 2026-10-19↩“BPI Labs, 12393 Belcher Rd S Suite 450, Largo, FL”
- 4.FDA Form 483 inspectional observations, BPI Labs, LLC, issued 2026-04-17FDAretrieved 2026-04-17↩“Liraglutide Injection, 18 mg/3 mL (6 mg/mL)”
- 5.FDA: 483 Issued 02/21/2025 (PDF - 338 KB)U.S. Food and Drug Administration↩
- 6.FDA: 483 Issued 04/30/2021 (PDF - 2 MB)U.S. Food and Drug Administration↩
- 7.Compounding inspections, recalls, and other actionsU.S. Food and Drug Administrationretrieved 2026-11-20↩
- 8.Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration↩
- 9.
- 10.
A pharmacy’s record can change after the day we read it: check its license with its state board before you fill a prescription. An FDA document is an allegation or an observation the FDA has published, not a court finding. This page is educational and is not medical advice.